Impact of the FDA roadmap and perspectives for regulatory use of new approach methodologies in Japanese pharmaceutical companies.
Authors: Araki T, Naraoka H, Asakawa Y, Usui T, Kakiuchi D, Kurashige S, Shinozawa T, Nakamura K, Noda T, Nishikawa S, Suzuki M
Journal: NAM journal
acceptance commitment therapy
mental health
open access